Skip to content
PubMed This is a summary of 15 peer-reviewed journal articles Updated
Intensive Care Medicine

Understanding Acute Interstitial Pneumonia

At a Glance

Acute Interstitial Pneumonia (AIP) is a sudden, rare, and life-threatening lung condition that requires immediate intensive care. While the disease causes severe lung damage and breathing failure, patients can achieve a full recovery with aggressive treatments like mechanical ventilation and steroids.

If you are reading this, your loved one is likely facing a sudden, overwhelming medical crisis. Acute Interstitial Pneumonia (AIP)—historically known as Hamman-Rich syndrome—is a rare and aggressive condition that strikes without warning, often in people who were previously healthy [1][2]. It is natural to feel a sense of shock and overwhelming uncertainty; AIP moves with a speed that can leave families and medical teams scrambling for answers [3][4].

Orienting Facts for Families

In the middle of an ICU crisis, it is helpful to have a few stabilizing points of reference. While AIP is a serious and life-threatening diagnosis, it is a recognized medical event with a specific management plan.

  1. AIP is a recognized pattern of injury. Although the cause is “idiopathic” (meaning unknown), doctors treat it as a specific form of Acute Respiratory Distress Syndrome (ARDS) [3][5]. This means the medical team is following intensive, established protocols for managing severe lung failure.
  2. Treatment is aggressive and immediate. Management typically involves high-dose corticosteroids (medications to reduce massive inflammation) and sophisticated breathing support, such as high-flow oxygen or mechanical ventilation [4]. In some cases, advanced “rescue” therapies like ECMO (a machine that breathes for the patient by oxygenating the blood outside the body) may be used [6][7].
  3. Complete recovery is possible. While the road is difficult, survivors of AIP can achieve a full clinical recovery, with some patients returning to normal lung function over time [1][8].

What to Expect in the ICU Environment

When you visit your loved one in the ICU, the environment can be incredibly intimidating. They will likely be heavily sedated to keep them comfortable and to allow the ventilator to do the work of breathing. They will not be able to speak due to the breathing tube. You will hear constant beeping from monitors and alarms—this is normal. These alarms simply tell the nursing team exactly what is happening in real time.

Understanding the Damage: DAD

To understand why AIP is so severe, doctors often look for a biological pattern called Diffuse Alveolar Damage (DAD). Think of the lungs like a sponge made of millions of tiny air sacs (alveoli). In AIP, these sacs are suddenly and severely injured [9][10].

  • The Exudative Phase: In the first few days, the lungs become “leaky.” A protein-rich fluid fills the air sacs, and a thick film (called a hyaline membrane) forms, making it incredibly hard for oxygen to pass into the bloodstream [11][12].
  • The Proliferative Phase: This is the “repair” phase. The body tries to heal the damage by growing new cells. However, this process can sometimes lead to fibrosis (scarring), which can make the lung tissue stiff and less efficient [11][13].

Looking Ahead

The honesty of the situation is that AIP is a “critical” condition in the truest sense of the word, with historically reported mortality rates as high as 60% [4][1]. However, medical terminology is evolving to help doctors be more precise, allowing them to focus on the specific shape and pattern of the lung injury to better tailor their aggressive care [14][15].

The focus of the ICU team right now is on stabilizing oxygen levels and giving the lungs the best possible environment to begin the repair process.

Common questions in this guide

What is Acute Interstitial Pneumonia (AIP)?
Acute Interstitial Pneumonia is a rare, rapidly developing lung condition that causes severe breathing failure. It often happens without warning in previously healthy individuals and is treated as a medical emergency in the ICU.
How is Acute Interstitial Pneumonia treated in the ICU?
Treatment is aggressive and immediately focuses on supporting the patient's breathing while reducing inflammation. Doctors typically use mechanical ventilation, high-dose corticosteroids, and sometimes advanced life support machines like ECMO.
What is Diffuse Alveolar Damage (DAD)?
Diffuse Alveolar Damage, or DAD, is the specific pattern of injury seen in the lungs of patients with AIP. It involves severe damage to the tiny air sacs in the lungs, creating a barrier that makes it very difficult for oxygen to enter the bloodstream.
Can a patient recover from Acute Interstitial Pneumonia?
Yes, complete recovery is possible. While AIP is a critical condition with high mortality rates, survivors can gradually regain normal lung function over time with intensive treatment and supportive care.
What questions should I ask the ICU doctor about AIP?
Ask the medical team about the specific pattern of lung injury, their protective ventilation strategy, and whether advanced rescue therapies like ECMO might be needed. You should also confirm that they have ruled out other causes like infections or autoimmune diseases.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on the morphological guidelines, how is my loved one's lung injury pattern currently being classified?
  2. 2.Does the imaging show a 'Diffuse Alveolar Damage' (DAD) pattern, and if so, what phase (exudative or proliferative) are they in?
  3. 3.Are we using 'lung-protective' ventilation strategies, and what are the specific targets for oxygen levels and pressure?
  4. 4.At what point would we consider 'rescue' therapies like ECMO or a transfer to a specialized lung center?
  5. 5.Have we ruled out all other possible triggers, such as infection or underlying autoimmune disease, to confirm this is idiopathic?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (15)
  1. 1

    A 45-Year-Old Woman with Acute Interstitial Pneumonia (Hamman-Rich Syndrome).

    Chertoff J, Alnuaimat H

    Turkish journal of anaesthesiology and reanimation 2017; (45(4)):244 doi:10.5152/TJAR.2017.98105.

    PMID: 28868178
  2. 2

    Pulmonary manifestations of VEXAS syndrome with acute interstitial pneumonia and diffuse alveolar hemorrhage: a case report and literature review.

    Puseljic M, Schmid J, Igrec J, et al.

    ARP rheumatology 2024; (3(2)):151-156.

    PMID: 38956997
  3. 3

    Trastuzumab Deruxtecan‒Related Interstitial Lung Disease/Pneumonitis: Computed Tomography Imaging Patterns to Guide Diagnosis and Management.

    Nishino M, Kusumoto M, Bankier AA, et al.

    JCO precision oncology 2023; (7()):e2300391 doi:10.1200/PO.23.00391.

    PMID: 38061008
  4. 4

    Hamman-Rich syndrome.

    Mastan A, Murugesu N, Hasnain A, et al.

    Respiratory medicine case reports 2018; (23()):13-17 doi:10.1016/j.rmcr.2017.10.008.

    PMID: 29159034
  5. 5

    Radiographic patterns of symptomatic radiation pneumonitis in lung cancer patients: Imaging predictors for clinical severity and outcome.

    Thomas R, Chen YH, Hatabu H, et al.

    Lung cancer (Amsterdam, Netherlands) 2020; (145()):132-139 doi:10.1016/j.lungcan.2020.03.023.

    PMID: 32447116
  6. 6

    Acute Onset Anti-Synthetase Syndrome With Pericardial Effusion and Non-Specific Interstitial Pneumonia.

    Shah A, Patel SR

    Journal of clinical medicine research 2016; (8(9)):683-7 doi:10.14740/jocmr2631w.

    PMID: 27540445
  7. 7

    Esophagopericardial fistula, septic shock and intracranial hemorrhage with hydrocephalus after lung transplantation.

    Schuurmans MM, Benden C, Moehrlen C, et al.

    Revista portuguesa de pneumologia 2017; (23(3)):156-159 doi:10.1016/j.rppnen.2017.01.005.

    PMID: 28237439
  8. 8

    Primary Sjogren's Syndrome Presenting as Acute Interstitial Pneumonitis/Hamman-Rich Syndrome.

    Khan A, Humayun M, Haider I, et al.

    Case reports in medicine 2016; (2016()):4136765 doi:10.1155/2016/4136765.

    PMID: 27818685
  9. 9

    Acute Lung Injury.

    Verma N, Hochhegger B, Mukhopadhyay S, et al.

    Journal of thoracic imaging 2025; (40(3)) doi:10.1097/RTI.0000000000000820.

    PMID: 39654323
  10. 10

    Pulmonary pathology and COVID-19: lessons from autopsy. The experience of European Pulmonary Pathologists.

    Calabrese F, Pezzuto F, Fortarezza F, et al.

    Virchows Archiv : an international journal of pathology 2020; (477(3)):359-372 doi:10.1007/s00428-020-02886-6.

    PMID: 32642842
  11. 11

    COVID-19: a Disease with a Potpourri of Histopathologic Findings-a Literature Review and Comparison to the Closely Related SARS and MERS.

    Malik P, Patel K, Akrmah M, et al.

    SN comprehensive clinical medicine 2021; (3(12)):2407-2434 doi:10.1007/s42399-021-01029-5.

    PMID: 34396046
  12. 12

    Postmortem Cardiopulmonary Pathology in Patients with COVID-19 Infection: Single-Center Report of 12 Autopsies from Lausanne, Switzerland.

    Berezowska S, Lefort K, Ioannidou K, et al.

    Diagnostics (Basel, Switzerland) 2021; (11(8)) doi:10.3390/diagnostics11081357.

    PMID: 34441292
  13. 13

    Pathological post-mortem findings in lungs infected with SARS-CoV-2.

    Damiani S, Fiorentino M, De Palma A, et al.

    The Journal of pathology 2021; (253(1)):31-40 doi:10.1002/path.5549.

    PMID: 32930394
  14. 14

    The demise of DIP, and the way forward.

    Mukhopadhyay S, Sansano I

    The European respiratory journal 2025; (66(6)) doi:10.1183/13993003.01745-2025.

    PMID: 41344732
  15. 15

    Update of the international multidisciplinary classification of the interstitial pneumonias: an ERS/ATS statement.

    Ryerson CJ, Adegunsoye A, Piciucchi S, et al.

    The European respiratory journal 2025; (66(6)) doi:10.1183/13993003.00158-2025.

    PMID: 40774805

This page is for informational purposes only and does not replace professional medical advice. Always discuss your loved one's specific condition and treatment plan directly with their ICU medical team.

Get notified when new evidence is published on Acute interstitial pneumonia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.